Neurizon Therapeutics (FRA:ECQ0) Days Payable: 0.00 (As of Dec. 2025)


What is Neurizon Therapeutics Days Payable?

Neurizon Therapeutics FRA:ECQ0 +20.37% Days Payable is 0.00 as of Dec. 2025. The stock has 2 warning signs investors should review. Among 702 Biotechnology companies, Neurizon Therapeutics ranks worse than 142450% on this metric.

Neurizon Therapeutics's average Accounts Payable for the six months ended in Dec. 2025 was €1.86 Mil. Neurizon Therapeutics's Cost of Goods Sold for the six months ended in Dec. 2025 was €0.00 Mil.

The historical rank and industry rank for Neurizon Therapeutics's Days Payable or its related term are showing as below:

During the past 13 years, Neurizon Therapeutics's highest Days Payable was 912.50. The lowest was 354.35. And the median was 672.17.

FRA:ECQ0's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Neurizon Therapeutics's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00).

Neurizon Therapeutics Days Payable Historical Data

* Premium members only.

The historical data trend for Neurizon Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurizon Therapeutics Days Payable Chart

Neurizon Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 888.25 661.02 365.00 0.00 0.00

Neurizon Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:ECQ0 vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Neurizon Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurizon Therapeutics Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurizon Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Neurizon Therapeutics's Days Payable falls into.


Neurizon Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Neurizon Therapeutics's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as

Days Payable (A: Jun. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jun. 2024 ) + Accounts Payable (A: Jun. 2025 )) / count ) / Cost of Goods Sold (A: Jun. 2025 )*Days in Period
=( (0.51 + 0.717) / 2 ) / 0*365
=0.6135 / 0*365
=N/A

Neurizon Therapeutics's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0.717 + 3.005) / 2 ) / 0*365 / 2
=1.861 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Neurizon Therapeutics (FRA:ECQ0) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Neurizon Therapeutics and its competitors. Over the past decade, Neurizon Therapeutics' Days Payable has ranged from 354.35 to 912.50. According to the industry distribution chart, Neurizon Therapeutics ranks #999999 out of 702 companies in the Biotechnology industry.
Is Neurizon Therapeutics' Days Payable too high?
Neurizon Therapeutics' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 354.35 to a high of 912.50. Based on the distribution chart, Neurizon Therapeutics ranks #999999 out of 702 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Neurizon Therapeutics' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Neurizon Therapeutics ranks #999999 out of 702 companies for Days Payable. This places Neurizon Therapeutics in the lower half of its industry. The industry median Days Payable is 113.56. Historically, Neurizon Therapeutics' own Days Payable has ranged from 354.35 to 912.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Neurizon Therapeutics and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neurizon Therapeutics's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurizon Therapeutics stock overvalued right now?
Neurizon Therapeutics (FRA:ECQ0) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Neurizon Therapeutics (FRA:ECQ0), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neurizon Therapeutics Business Description

Other Exchanges ECQ0:GermanyNUZ:Australia
Address 385 Bourke Street, Suite 2, Level 11, Melbourne, VIC, AUS, 3205
Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).